ZimVie Analyst Ratings
BenzingaApr 11 05:47 ET
Analysts Have Conflicting Sentiments on These Healthcare Companies: ZimVie Inc (ZIMV) and Merus (MRUS)
TipRanksApr 11 05:40 ET
ZimVie Analyst Ratings
BenzingaMar 5 06:43 ET
Analysts Offer Insights on Healthcare Companies: Ginkgo Bioworks Holdings (DNA), ZimVie Inc (ZIMV) and Veeva Systems (VEEV)
TipRanksMar 5 03:11 ET
Needham Sticks to Its Hold Rating for ZimVie Inc (ZIMV)
TipRanksFeb 29 06:15 ET
ZimVie Inc (ZIMV) Gets a Hold From Needham
TipRanksFeb 8 05:26 ET
ZimVie Analyst Ratings
BenzingaJan 4 08:13 ET
ZimVie Analyst Ratings
BenzingaDec 20, 2023 15:26 ET
Needham Keeps Their Hold Rating on ZimVie Inc (ZIMV)
TipRanksDec 18, 2023 12:35 ET
ZimVie Analyst Ratings
BenzingaNov 16, 2023 07:12 ET
JP Morgan Maintains Neutral on ZimVie, Lowers Price Target to $10
BenzingaNov 2, 2023 18:08 ET
Barclays Maintains Underweight on ZimVie, Raises Price Target to $11
BenzingaAug 8, 2023 06:40 ET
ZimVie Analyst Ratings
BenzingaAug 8, 2023 06:39 ET
Barclays Adjusts Price Target on ZimVie to $7 From $5, Keeps Underweight Rating
MT NewswiresMay 9, 2023 07:34 ET
Analysts' Opinions Are Mixed on These Healthcare Stocks: Apollo Medical Holdings (AMEH), Arcellx Inc (ACLX) and ZimVie Inc (ZIMV)
TipRanksMay 9, 2023 06:07 ET
Barclays Maintains Underweight on ZimVie, Raises Price Target to $7
BenzingaMay 9, 2023 05:58 ET
Barclays Adjusts ZimVie Price Target to $5 From $9, Maintains Underweight Rating
MT NewswiresMar 6, 2023 08:25 ET
ZimVie Analyst Ratings
Benzinga Analyst RatingsDec 21, 2022 07:07 ET
Barclays Initiates Coverage On ZimVie With Underweight Rating, Announces Price Target of $9
Benzinga Real-time NewsDec 21, 2022 07:07 ET
JPMorgan Initiates ZimVie at Neutral, Sets Price Target at $20
MT NewswiresJun 17, 2022 09:41 ET
No Data
No Data